or Try an Advanced Search...

    Liver Disease Stocks List

    Symbol Grade Name % Change
    ALNY D Alnylam Pharmaceuticals, Inc. 0.00
    GALT B Galectin Therapeutics Inc. 0.00
    GILD F Gilead Sciences, Inc. 0.00
    HEPA F Hepion Pharmaceuticals, Inc. 0.00
    GYRE D Gyre Therapeutics, Inc. 0.00
    NTLA F Intellia Therapeutics, Inc. 0.00
    GNFT D GENFIT S.A. 0.00
    MIRM D Mirum Pharmaceuticals, Inc. 0.00
    TARA D ArTara Therapeutics, Inc. 0.00
    ALGS D Aligos Therapeutics, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
    Related Stock Lists: Medicine Biopharmaceutical Hepatitis Non Alcoholic Fatty Liver Disease Steatohepatitis Alcohol Hepatitis B Hepatology Amyloid Amyloidosis Antitrypsin Deficiency Biotechnology Chronic Liver Disease Chronic Liver Diseases Coronavirus Gilead Sciences Hepatotoxins Lipid Liver Liver Fibrosis

    Related ETFs - A few ETFs which own one or more of the above listed Liver Disease stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 6.39
    GERM C ETFMG Treatments Testing and Advancements ETF 6.22
    BTEC C Principal Healthcare Innovators Index ETF 4.02
    ARKG D ARK Genomic Revolution Multi-Sector ETF 3.73
    FBT D First Trust Amex Biotech Index Fund 3.3
    View all Liver Disease ETFs...
    Compare ETFs
    Compare ARKG to FBT Compare GERM to BTEC Compare GNOM to ARKG

        Liver Disease Stocks Recent News

        Date Stock Title
        May 2 ALNY Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2024 Earnings Call Transcript
        May 2 ALNY Alnylam Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 GILD Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
        May 2 ALNY Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
        May 2 ALNY Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
        May 2 TARA Protara Therapeutics GAAP EPS of -$0.97
        May 2 ALNY Alnylam Pharmaceuticals Non-GAAP EPS of -$0.16 beats by $0.32, revenue of $494.3M beats by $67.44M
        May 2 TARA Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
        May 2 ALNY Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
        May 2 NTLA Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
        May 1 MIRM Mirum Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
        May 1 ALNY Alnylam Pharmaceuticals Q1 2024 Earnings Preview
        May 1 ALNY Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
        Apr 30 ALGS Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
        Apr 30 GILD Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
        Apr 30 MIRM Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
        Apr 30 ALNY Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics
        Apr 30 ALNY Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
        Apr 29 NTLA Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
        Apr 29 GILD Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
        Related Stock Lists: Hepatitis Non Alcoholic Fatty Liver Disease Steatohepatitis Medicine Alcohol Biopharmaceutical Hepatology Amyloid Amyloidosis Antitrypsin Deficiency Biotechnology Clinical Medicine Drug Development Fatty Liver Disease Hepatitis B Liver Liver Fibrosis Primary Biliary Cholangitis Transthyretin Acid
        Liver Disease

        Liver disease (also called hepatic disease) is a type of damage to or disease of the liver. Whenever the course of the problem lasts long, chronic liver disease ensues.

        More about Liver Disease
        Browse All Tags